NPI: 1336173269 · BURBANK, CA 91505 · General Acute Care Hospital · NPI assigned 07/10/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS) |
| NPI Enumeration Date | 07/10/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 138,741 | $2.91M |
| 2019 | 115,197 | $3.98M |
| 2020 | 82,841 | $1.59M |
| 2021 | 106,258 | $2.29M |
| 2022 | 119,462 | $3.51M |
| 2023 | 155,625 | $4.00M |
| 2024 | 153,153 | $3.71M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0450 | Emergency room services | 103,445 | 94,506 | $5.38M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 11,161 | 10,054 | $1.37M |
| 70450 | Computed tomography, head or brain; without contrast material | 8,875 | 8,612 | $953K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,032 | 4,735 | $844K |
| 80053 | Comprehensive metabolic panel | 32,447 | 29,600 | $757K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7,241 | 7,123 | $741K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,334 | 4,155 | $719K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6,428 | 6,270 | $690K |
| 99199 | Unlisted special service, procedure or report | 10,542 | 9,233 | $512K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 19,171 | 18,068 | $500K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 26,169 | 24,697 | $481K |
| 80048 | Basic metabolic panel (calcium, ionized) | 25,858 | 23,913 | $427K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 58,416 | 52,573 | $406K |
| 71045 | Radiologic examination, chest; single view | 22,821 | 21,838 | $365K |
| 96375 | Therapeutic injection; each additional sequential IV push | 17,703 | 15,248 | $334K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6,543 | 6,197 | $316K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,151 | 3,887 | $314K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,176 | 4,085 | $273K |
| 96361 | Intravenous infusion, hydration; each additional hour | 11,771 | 10,858 | $257K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,231 | 6,423 | $249K |
| Z7502 | 6,986 | 6,885 | $246K | |
| 0160 | 3,027 | 1,640 | $238K | |
| 0214 | 108 | 99 | $235K | |
| 71046 | Radiologic examination, chest; 2 views | 8,696 | 8,493 | $231K |
| 0762 | 3,100 | 1,748 | $222K | |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,753 | 3,487 | $206K |
| 0121 | 194 | 188 | $204K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,354 | 1,329 | $174K |
| 84484 | 21,434 | 17,736 | $166K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,821 | 9,484 | $151K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,406 | 3,297 | $136K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,796 | 5,556 | $119K |
| 81001 | 21,833 | 20,836 | $117K | |
| 70496 | 860 | 838 | $99K | |
| 83690 | 14,426 | 13,727 | $98K | |
| 0250 | 18,855 | 11,604 | $97K | |
| Z9725 | 2,903 | 2,861 | $87K | |
| 83880 | 6,203 | 5,936 | $87K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,315 | 7,090 | $87K |
| 76830 | Ultrasound, transvaginal | 2,429 | 2,369 | $83K |
| J7030 | Infusion, normal saline solution , 1000 cc | 11,073 | 9,803 | $74K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,828 | 3,365 | $70K |
| 70486 | 722 | 710 | $66K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 172 | 168 | $66K |
| 81003 | 14,497 | 13,822 | $65K | |
| 72100 | 2,364 | 2,330 | $65K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 402 | 383 | $64K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,070 | 1,831 | $64K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 7,860 | 7,548 | $61K |
| J3490 | Unclassified drugs | 14,548 | 10,160 | $59K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 14,571 | 12,747 | $58K |
| 84703 | 8,951 | 8,600 | $56K | |
| 87040 | 6,348 | 3,465 | $55K | |
| 93971 | 903 | 879 | $55K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 9,466 | 7,827 | $52K |
| 70498 | 601 | 588 | $52K | |
| 96376 | 4,681 | 3,542 | $52K | |
| 73630 | 2,000 | 1,897 | $50K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 389 | 386 | $49K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,122 | 1,995 | $48K |
| 73610 | 2,147 | 2,051 | $47K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,073 | 1,406 | $46K |
| 73562 | 2,196 | 2,045 | $45K | |
| J7050 | Infusion, normal saline solution, 250 cc | 3,132 | 2,156 | $43K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,295 | 2,059 | $41K |
| 90715 | 1,575 | 1,560 | $38K | |
| 72040 | 1,252 | 1,246 | $38K | |
| 59025 | Fetal non-stress test | 4,708 | 2,473 | $38K |
| 73130 | 1,301 | 1,232 | $38K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 9,680 | 9,065 | $37K |
| 73030 | 1,772 | 1,703 | $36K | |
| 85379 | 3,703 | 3,614 | $36K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,460 | 3,290 | $35K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 273 | 267 | $34K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,712 | 2,618 | $32K |
| 84702 | 3,199 | 2,800 | $31K | |
| 0710 | 3,024 | 2,914 | $30K | |
| 80143 | 1,458 | 1,400 | $29K | |
| 80179 | 1,440 | 1,393 | $29K | |
| 0761 | 1,917 | 1,596 | $28K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,409 | 1,277 | $28K |
| 73110 | 942 | 903 | $27K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 891 | 842 | $26K |
| J1815 | Injection, insulin, per 5 units | 1,974 | 1,367 | $26K |
| 87081 | 3,275 | 3,140 | $24K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5,399 | 2,075 | $24K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,325 | 1,295 | $24K |
| 96367 | 1,084 | 985 | $24K | |
| 83605 | 3,957 | 3,608 | $24K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,243 | 1,233 | $24K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,422 | 4,060 | $24K |
| 0760 | 1,761 | 1,508 | $22K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 685 | 635 | $22K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 611 | 606 | $20K |
| 85610 | 4,980 | 4,598 | $20K | |
| 0122 | 267 | 258 | $18K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,461 | 897 | $18K |
| 97162 | 667 | 650 | $17K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,073 | 2,714 | $16K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 1,056 | 686 | $16K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,273 | 779 | $16K |
| 73140 | 714 | 697 | $15K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,898 | 3,540 | $15K |
| 0260 | 205 | 153 | $14K | |
| 83735 | 3,390 | 2,795 | $14K | |
| 71250 | 238 | 235 | $13K | |
| 74018 | 761 | 740 | $13K | |
| J2060 | Injection, lorazepam, 2 mg | 2,672 | 2,332 | $13K |
| 86901 | 4,651 | 4,017 | $13K | |
| 0370 | 701 | 680 | $13K | |
| 71101 | 365 | 358 | $12K | |
| 84145 | 1,292 | 1,232 | $12K | |
| 87077 | 1,879 | 1,832 | $12K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,132 | 1,652 | $12K |
| 87186 | 2,147 | 2,098 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,079 | 2,041 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 393 | 393 | $11K |
| 86900 | 4,707 | 4,072 | $11K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 82 | 81 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 992 | 966 | $11K |
| 0270 | 10,045 | 6,079 | $10K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 73 | 72 | $10K |
| 86850 | 2,696 | 2,573 | $10K | |
| 85055 | 977 | 906 | $10K | |
| 77336 | 368 | 153 | $10K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,052 | 2,018 | $10K |
| 85730 | 2,388 | 2,242 | $10K | |
| 80061 | Lipid panel | 1,283 | 1,151 | $9K |
| 0335 | 395 | 265 | $9K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,815 | 1,061 | $9K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,759 | 2,483 | $9K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 99 | 95 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,702 | 1,665 | $8K |
| 86140 | 1,918 | 1,862 | $8K | |
| 36415 | Collection of venous blood by venipuncture | 6,351 | 4,709 | $8K |
| 87631 | 197 | 197 | $8K | |
| 0360 | 797 | 748 | $7K | |
| 76870 | 150 | 147 | $7K | |
| J2704 | Injection, propofol, 10 mg | 1,778 | 1,698 | $7K |
| 73502 | 339 | 320 | $7K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 151 | 151 | $7K |
| 85652 | 1,635 | 1,578 | $6K | |
| 80076 | 550 | 532 | $6K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 573 | 479 | $6K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,074 | 1,995 | $6K |
| 73590 | 203 | 190 | $6K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 130 | 127 | $6K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,964 | 1,859 | $6K |
| 97161 | 163 | 155 | $5K | |
| 73080 | 163 | 160 | $5K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 62 | 51 | $5K |
| 0272 | 1,112 | 1,069 | $5K | |
| 86141 | 856 | 846 | $5K | |
| G0378 | Hospital observation service, per hour | 207 | 140 | $5K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 757 | 687 | $5K |
| 0171 | Inj, epinephrine (belcher) | 330 | 329 | $5K |
| 85027 | 1,881 | 1,606 | $4K | |
| 76801 | 143 | 138 | $4K | |
| Z7610 | 555 | 442 | $4K | |
| 97116 | 763 | 583 | $4K | |
| 0023 | Pin srv add 30 min pr m | 22 | 16 | $4K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,329 | 1,117 | $4K |
| 87807 | 976 | 943 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,445 | 1,330 | $4K |
| 82550 | 586 | 536 | $3K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 357 | 286 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 299 | 299 | $3K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 717 | 494 | $3K |
| 93970 | 42 | 42 | $3K | |
| 0301 | 1,314 | 1,185 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 14 | 13 | $3K |
| 73560 | 148 | 136 | $3K | |
| J1953 | Injection, levetiracetam, 10 mg | 175 | 150 | $3K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,876 | 1,689 | $3K |
| 84439 | 455 | 451 | $3K | |
| 76641 | 69 | 69 | $3K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 359 | 336 | $3K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 441 | 429 | $3K |
| 0324 | 659 | 634 | $3K | |
| 77300 | 26 | 26 | $2K | |
| 86920 | 62 | 57 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 428 | 416 | $2K |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 6,175 | 5,402 | $2K |
| 0258 | 799 | 737 | $2K | |
| 0940 | 335 | 237 | $2K | |
| 80047 | 301 | 294 | $2K | |
| 85014 | 338 | 325 | $2K | |
| J1630 | Injection, haloperidol, up to 5 mg | 266 | 247 | $2K |
| 87210 | 297 | 289 | $2K | |
| 0300 | 2,168 | 1,762 | $2K | |
| 72170 | 91 | 90 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 162 | 139 | $2K |
| A9585 | Injection, gadobutrol, 0.1 ml | 129 | 125 | $2K |
| 0042T | 15 | 15 | $2K | |
| 29125 | 29 | 29 | $1K | |
| 0510 | 614 | 590 | $1K | |
| J1644 | Injection, heparin sodium, per 1000 units | 571 | 303 | $1K |
| 82077 | 42 | 39 | $1K | |
| 87147 | 111 | 111 | $1K | |
| 87205 | 414 | 369 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 124 | 98 | $1K |
| J1453 | Injection, fosaprepitant, 1 mg | 21 | 12 | $1K |
| 96417 | 171 | 111 | $1K | |
| 0352 | 629 | 613 | $1K | |
| 72131 | 13 | 13 | $1K | |
| J1836 | Injection, metronidazole, 10 mg | 124 | 102 | $1K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 12 | 12 | $971.54 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 263 | 206 | $925.55 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 24 | 24 | $924.28 |
| 88342 | 103 | 103 | $848.69 | |
| 92610 | 52 | 52 | $833.93 | |
| A9270 | Non-covered item or service | 936 | 290 | $814.66 |
| 12001 | 124 | 124 | $787.46 | |
| 93880 | 12 | 12 | $753.28 | |
| 93017 | 28 | 27 | $722.35 | |
| 29515 | 115 | 114 | $710.61 | |
| 86308 | 161 | 159 | $708.32 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 207 | 180 | $687.86 |
| 76376 | 47 | 43 | $676.31 | |
| 76770 | 16 | 15 | $661.26 | |
| 87070 | 154 | 145 | $635.95 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 173 | 168 | $625.49 |
| 0361 | 35 | 27 | $613.50 | |
| 72072 | 15 | 15 | $601.23 | |
| 77066 | Tomosynthesis, mammo | 13 | 13 | $587.73 |
| C1769 | Guide wire | 12 | 12 | $566.61 |
| 92526 | 28 | 25 | $533.32 | |
| 82803 | 35 | 33 | $523.72 | |
| 0637 | 963 | 415 | $518.25 | |
| 0350 | 62 | 62 | $502.90 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 13 | 13 | $480.80 |
| 0636 | 3,607 | 2,762 | $474.17 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 293 | 118 | $469.30 |
| 86592 | 90 | 89 | $464.92 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 12 | 12 | $403.88 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 53 | 40 | $403.28 |
| Z9727 | 13 | 13 | $390.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 127 | 109 | $377.82 |
| A4649 | Surgical supply; miscellaneous | 413 | 293 | $367.49 |
| 84100 | 191 | 143 | $363.58 | |
| 77080 | 12 | 12 | $322.95 | |
| 12011 | 28 | 28 | $321.60 | |
| 96415 | 37 | 26 | $316.37 | |
| 82140 | 42 | 39 | $302.94 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 80 | 77 | $270.72 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 90 | 69 | $270.25 |
| 71010 | 40 | 30 | $269.52 | |
| 10061 | 12 | 12 | $234.75 | |
| 88307 | 25 | 25 | $220.06 | |
| 76642 | 12 | 12 | $218.93 | |
| 29130 | 39 | 39 | $186.37 | |
| 82728 | 43 | 40 | $186.08 | |
| 81025 | 51 | 51 | $179.53 | |
| 71020 | 17 | 15 | $177.79 | |
| 73090 | 12 | 12 | $168.61 | |
| 12002 | 24 | 24 | $144.38 | |
| J0456 | Injection, azithromycin, 500 mg | 45 | 37 | $139.02 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 61 | 54 | $122.23 |
| 87899 | 18 | 12 | $120.80 | |
| 82247 | 35 | 29 | $109.34 | |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 81 | 78 | $106.66 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 39 | 37 | $104.05 |
| 0306 | 1,171 | 1,101 | $102.62 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 539 | 494 | $100.55 |
| 0351 | 336 | 331 | $95.49 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 40 | 29 | $90.79 |
| A4217 | Sterile water/saline, 500 ml | 18 | 16 | $81.49 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 25 | 25 | $75.93 |
| 29505 | 12 | 12 | $75.19 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 159 | 158 | $73.53 |
| J1171 | Injection, hydromorphone, 0.1 mg | 36 | 28 | $73.14 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 28 | 27 | $62.15 |
| 99152 | 12 | 12 | $56.65 | |
| 83615 | 12 | 12 | $49.44 | |
| 84550 | 26 | 25 | $48.75 | |
| 96040 | 27 | 27 | $34.80 | |
| 82009 | 13 | 12 | $32.39 | |
| 0730 | 303 | 290 | $29.84 | |
| 82248 | 14 | 12 | $21.28 | |
| 99153 | Mod sedat endo service >5yrs | 29 | 28 | $21.12 |
| J1940 | Injection, furosemide, up to 20 mg | 17 | 14 | $18.89 |
| 0305 | 1,092 | 1,023 | $18.76 | |
| 81002 | 13 | 12 | $7.89 | |
| 0307 | 461 | 446 | $4.06 | |
| Q5001 | Hospice or home health care provided in patient's home/residence | 34 | 26 | $0.06 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 162 | 154 | $0.01 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 151 | 145 | $0.01 |
| 0424 | 92 | 89 | $0.00 | |
| 0302 | 820 | 680 | $0.00 | |
| 0278 | 39 | 38 | $0.00 | |
| 0402 | 65 | 64 | $0.00 | |
| 0320 | 14 | 14 | $0.00 | |
| 15853 | 13 | 12 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 1,846 | 1,163 | $0.00 |
| 0410 | 649 | 631 | $0.00 | |
| 0771 | 296 | 254 | $0.00 | |
| 0310 | 45 | 45 | $0.00 | |
| 0720 | 115 | 115 | $0.00 | |
| 0420 | 91 | 88 | $0.00 | |
| 0255 | 47 | 45 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 26 | 25 | $0.00 |